HBVr is a well-known complication in HBV-infected RA patients receiving anti-TNF-α therapy, characterized by the reappearance or rise of HBV DNA in their sera and often associated with hepatocellular injury [16,17,18,19]. This evidence concerns the gene TNF and rheumatoid arthritis.